结直肠癌

Regional Chief of Surgery

MedStar Health

Baltimore

MD

利益声明

DES declares that he has no competing interests.

Associate Program Director

Department of Surgery

MedStar Franklin Square Medical Center

Baltimore

MD

利益声明

DML declares that he has no competing interests.

Co-Director of Medical Oncology

Director of Immuno-Oncology

MedStar Franklin Square Medical Center

Harry and Jeanette Weinberg Cancer Institute

Baltimore

MD

利益声明

PPK declares that she has no competing interests.

Department of Radiation Oncology

MedStar Franklin Square Medical Center

Baltimore

MD

利益声明

KANC declares that she has no competing interests.

Dr David E. Stein, Dr David M Lisle, Dr Pallavi P Kumarm and Dr Kamila A Nowak-Choi would like to gratefully acknowledge Dr Juan L. Poggio, Dr Jascha Rubin, Dr Najjia Mahmoud, Dr Emily Carter Paulson, Dr Gary Atkin, Dr Anne Ballinger, Dr Mark O'Hara, Dr Mark Harrison, and Dr Robert Glynne-Jones, previous contributors to this topic.

利益声明

JLP, JR, NM, ECP, MOH, GA, and AB declare that they have no competing interests. MH is the chair of the Mount Vernon Upper GI Tumour Site Specific Group and a member of the National Cancer Research Institute anal, rectal, and advanced colorectal groups. He has also received honoraria for speaking and has been supported to attend international meetings in GI cancer from Roche. He has also received research funding from Pfizer for a trial in rectal cancer. RGJ is the chief medical adviser to the charity Bowel Cancer UK. He has received honoraria for lectures from Roche, Sanofi, and Pfizer. He has received funding for the EXTRA study, involving capecitabine and radiotherapy in anal cancer, published in the International Journal of Radiation Biology Physics. RGJ has also received funding and free cetuximab for an ongoing phase I/II study integrating cetuximab into chemoradiation in rectal cancer, and has an agreement from Roche to supply bevacizumab for 3 months to 60 patients in one randomised phase II study as neoadjuvant chemotherapy in rectal cancer (BACCHUS). He has also been supported by Roche to attend international meetings in GI cancer.